Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
1.485
-0.075 (-4.82%)
Nov 21, 2024, 11:54 AM EST - Market open
Cellectar Biosciences Employees
Cellectar Biosciences had 20 employees as of December 31, 2023. The number of employees increased by 5 or 33.33% compared to the previous year.
Employees
20
Change (1Y)
5
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,505,360
Market Cap
53.24M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Agenus | 389 |
Xtant Medical Holdings | 215 |
Mural Oncology | 117 |
VolitionRx | 110 |
DBV Technologies | 105 |
Shattuck Labs | 75 |
Boundless Bio | 72 |
Immuneering | 68 |
CLRB News
- 3 hours ago - NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225) - Business Wire
- 3 days ago - Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update - GlobeNewsWire
- 7 days ago - Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225 - GlobeNewsWire
- 9 days ago - Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer - GlobeNewsWire
- 9 days ago - Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024 - GlobeNewsWire
- 14 days ago - Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024 - GlobeNewsWire
- 19 days ago - Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q - GlobeNewsWire